Abstract
Neutrophilic inflammation and
Pseudomonas aeruginosa
infection have been implicated in the pathogenesis and progression of bronchiectasis. However, the mechanisms underlying the inflammasome activation and neutrophil extracellular traps (NETs) formation, which are triggered by lipopolysaccharide (LPS), thereby fostering relentless neutrophilic inflammation and airway destruction, remain poorly understood. Here, we investigated how nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome activation modulates NET formation, epithelial inflammation, and injury in bronchiectasis. Compared with those in the stable state, interleukin-1β levels in the exacerbation state were greater and were correlated with blood neutrophil counts. LPS triggered neutrophil NLRP3 inflammasome activation and induced NET formation. At exacerbation, caspase-1 p20, DNA-myeloperoxidase, and DNA-neutrophil elastase expression levels were increased compared with those in the stable state. LPS triggered the first signal, nuclear factor-κB, for NLRP3 inflammasome activation within the airway epithelium, leading to neutrophil chemotactic factor release. NETs served as the secondary signal for thorough NLRP3 inflammasome activation. Acting synergistically with LPS, NETs amplified epithelial inflammation, up-regulating mucin 5AC expression while suppressing zona occludens-1 and α-tubulin expression. Both MCC950 and Z-VAD-FMK inhibited NLRP3 inflammasome activation, whereas GSK484 and LDC7559 suppressed NET formation. Collectively, NLRP3 inflammasome activation facilitates NET formation in bronchiectasis, aggravating inflammation and eliciting injury to epithelial cells.
Topics

No keywords indexed for this article. Browse by subject →

References
51
[1]
Bronchiectasis

James D. Chalmers, Anne B. Chang, Sanjay H. Chotirmall et al.

Nature Reviews Disease Primers 2018 10.1038/s41572-018-0042-3
[2]
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations

Stefano Aliberti, Pieter C Goeminne, Anne E O'Donnell et al.

The Lancet Respiratory Medicine 2022 10.1016/s2213-2600(21)00277-0
[3]
Aliberti S, Ringshausen FC, Dhar R, Haworth CS, Loebinger MR, Dimakou K, Crichton ML, De Soyza A, Vendrell M, Burgel P-R, et al. Objective sputum colour assessment and clinical outcomes in bronchiectasis: Data from the European bronchiectasis registry (EMBARC). Eur Respir J. 2024;63(4):2301554. 10.1183/13993003.01554-2023
[5]
Chalmers JD, Moffitt KL, Suarez-Cuartin G, Sibila O, Finch S, Furrie E, Dicker A, Wrobel K, Elborn JS, Walker B, et al. Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis. Am J Respir Crit Care Med. 2017;195(10):1384–1393. 10.1164/rccm.201605-1027oc
[6]
Inflammasomes: mechanism of action, role in disease, and therapeutics

Haitao Guo, Justin B Callaway, Jenny P-Y Ting

Nature Medicine 10.1038/nm.3893
[7]
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

Nathan Kelley, Devon Jeltema, Yanhui Duan et al.

International Journal of Molecular Sciences 10.3390/ijms20133328
[9]
Kim RY, Pinkerton JW, Essilfie AT, Robertson AAB, Baines KJ, Brown AC, Mayall JR, Ali MK, Starkey MR, Hansbro NG, et al. Role for NLRP3 inflammasome-mediated, IL-1beta-dependent responses in severe, steroid-resistant asthma. Am J Respir Crit Care Med. 2017;196(3):283–297. 10.1164/rccm.201609-1830oc
[10]
Kim RY, Pinkerton JW, Gibson PG, Cooper MA, Horvat JC, Hansbro PM. Inflammasomes in COPD and neutrophilic asthma. Thorax. 2015;70(12):1199–1201. 10.1136/thoraxjnl-2014-206736
[11]
Faner R, Sobradillo P, Noguera A, Gomez C, Cruz T, Lopez-Giraldo A, Ballester E, Soler N, Arostegui JI, Pelegrin P, et al. The inflammasome pathway in stable COPD and acute exacerbations. ERJ Open Res. 2016;2(3):00002–02016. 10.1183/23120541.00002-2016
[12]
Perea L, Bottier M, Cant E, Richardson H, Dicker AJ, Shuttleworth M, Giam YH, Abo-Leyah H, Finch S, Huang JTJ, et al. Airway IL-1β is related to disease severity and mucociliary function in bronchiectasis. Eur Respir J. 2024;64(2):2301966. 10.1183/13993003.01966-2023
[13]
Neutrophil extracellular traps in immunity and disease

Venizelos Papayannopoulos

Nature Reviews Immunology 2017 10.1038/nri.2017.105
[14]
Keir HR, Shoemark A, Dicker AJ, Perea L, Pollock J, Giam YH, Suarez-Cuartin G, Crichton ML, Lonergan M, Oriano M, et al. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: An international, observational, multicohort study. Lancet Respir Med. 2021;9(8):873–884. 10.1016/s2213-2600(20)30504-x
[15]
Noncanonical inflammasome signaling elicits gasdermin D–dependent neutrophil extracellular traps

Kaiwen W. Chen, Mercedes Monteleone, Dave Boucher et al.

Science Immunology 10.1126/sciimmunol.aar6676
[16]
Gasdermin D plays a vital role in the generation of neutrophil extracellular traps

Gabriel Sollberger, Axel Choidas, Garth Lawrence Burn et al.

Science Immunology 10.1126/sciimmunol.aar6689
[17]
NLRP3 Inflammasome Assembly in Neutrophils Is Supported by PAD4 and Promotes NETosis Under Sterile Conditions

Patrick Münzer, Roberto Negro, Shoichi Fukui et al.

Frontiers in Immunology 2021 10.3389/fimmu.2021.683803
[18]
Chauhan D, Demon D, Vande Walle L, Paerewijck O, Zecchin A, Bosseler L, Santoni K, Planes R, Ribo S, Fossoul A, et al. GSDMD drives canonical inflammasome-induced neutrophil pyroptosis and is dispensable for NETosis. EMBO Rep. 2022;23(10): Article e54277. 10.15252/embr.202154277
[21]
Jiang D, Wenzel SE, Wu Q, Bowler RP, Schnell C, Chu HW. Human neutrophil elastase degrades SPLUNC1 and impairs airway epithelial defense against bacteria. PLOS ONE. 2013;8(5): Article e64689. 10.1371/journal.pone.0064689
[22]
Chalmers JD, Smith MP, McHugh BJ, Doherty C, Govan JR, Hill AT. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2012;186(7):657–665. 10.1164/rccm.201203-0487oc
[23]
Vidaillac C, Chotirmall SH. Pseudomonas aeruginosa in bronchiectasis: Infection, inflammation, and therapies. Expert Rev Respir Med. 2021;15(5):649–662. 10.1080/17476348.2021.1906225
[24]
Woo TE, Lim R, Surette MG, Waddell B, Bowron JC, Somayaji R, Duong J, Mody CH, Rabin HR, Storey DG, et al. Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis. ERJ Open Res. 2018;4(2):00162–02017.
[25]
Martinez-Garcia MA, Oscullo G, Posadas T, Zaldivar E, Villa C, Dobarganes Y, Giron R, Olveira C, Maiz L, Garcia-Clemente M, et al. Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis. Clin Microbiol Infect. 2021;27(3):428–434. 10.1016/j.cmi.2020.04.007
[26]
Wang H, Ji XB, Mao B, Li CW, Lu HW, Xu JF. Pseudomonas aeruginosa isolation in patients with non-cystic fibrosis bronchiectasis: A retrospective study. BMJ Open. 2018;8(3): Article e014613. 10.1136/bmjopen-2016-014613
[28]
Liu C, Zhou Y, Tu Q, Yao L, Li J, Yang Z. Alpha-linolenic acid pretreatment alleviates NETs-induced alveolar macrophage pyroptosis by inhibiting pyrin inflammasome activation in a mouse model of sepsis-induced ALI/ARDS. Front Immunol. 2023;14:1146612. 10.3389/fimmu.2023.1146612
[29]
Keir HR, Chalmers JD. Neutrophil extracellular traps in chronic lung disease: Implications for pathogenesis and therapy. Eur Respir Rev. 2022;31(163).
[30]
FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation

Jun Jacob Hu, Xing Liu, Shiyu Xia et al.

Nature Immunology 10.1038/s41590-020-0669-6
[31]
No NETs no TIME: Crosstalk between neutrophil extracellular traps and the tumor immune microenvironment

Qi Fang, Antonia Margarethe Stehr, Elisabeth Naschberger et al.

Frontiers in Immunology 2022 10.3389/fimmu.2022.1075260
[32]
Bedi P, Davidson DJ, McHugh BJ, Rossi AG, Hill AT. Blood neutrophils are reprogrammed in bronchiectasis. Am J Respir Crit Care Med. 2018;198(7):880–890. 10.1164/rccm.201712-2423oc
[34]
Neutrophil-derived IL-1β Is Sufficient for Abscess Formation in Immunity against Staphylococcus aureus in Mice

John S. Cho, Yi Guo, Romela Irene Ramos et al.

PLOS Pathogens 2012 10.1371/journal.ppat.1003047
[35]
Zhang T, Du H, Feng S, Wu R, Chen T, Jiang J, Peng Y, Ye C, Fang R. NLRP3/ASC/Caspase-1 axis and serine protease activity are involved in neutrophil IL-1beta processing during Streptococcus pneumoniae infection. Biochem Biophys Res Commun. 2019;513(3):675–680. 10.1016/j.bbrc.2019.04.004
[36]
Potere N, Del Buono MG, Caricchio R, Cremer PC, Vecchie A, Porreca E, Gasperina DD, Dentali F, Abbate A, Bonaventura A. Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications. EBioMedicine. 2022;85: Article 104299. 10.1016/j.ebiom.2022.104299
[37]
McHugh BJ, Wang R, Li HN, Beaumont PE, Kells R, Stevens H, Young L, Rossi AG, Gray RD, Dorin JR, et al. Cathelicidin is a “fire alarm”, generating protective NLRP3-dependent airway epithelial cell inflammatory responses during infection with Pseudomonas aeruginosa. PLOS Pathog. 2019;15(4): Article e1007694. 10.1371/journal.ppat.1007694
[40]
Kumar V. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury. Front Immunol. 2020;11:1722. 10.3389/fimmu.2020.01722
[41]
Jia J, Wang M, Ma Y, Meng J, Zhu D, Chen X, Shi H, Sun Y, Liu H, Cheng X, et al. Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset still’s disease. BMC Med. 2023;21(1):507. 10.1186/s12916-023-03231-9
[42]
Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still’s disease

Qiongyi Hu, Hui Shi, Ting Zeng et al.

Arthritis Research & Therapy 2019 10.1186/s13075-018-1800-z
[43]
Tan HT, Hagner S, Ruchti F, Radzikowska U, Tan G, Altunbulakli C, Eljaszewicz A, Moniuszko M, Akdis M, Akdis CA, et al. Tight junction, mucin, and inflammasome-related molecules are differentially expressed in eosinophilic, mixed, and neutrophilic experimental asthma in mice. Allergy. 2019;74(2):294–307. 10.1111/all.13619
[44]
Kao SS, Ramezanpour M, Bassiouni A, Wormald PJ, Psaltis AJ, Vreugde S. The effect of neutrophil serine proteases on human nasal epithelial cell barrier function. Int Forum Allergy Rhinol. 2019;9(10):1220–1226. 10.1002/alr.22401
[45]
Liu T, Zhou YT, Wang LQ, Li LY, Bao Q, Tian S, Chen MX, Chen HX, Cui J, Li CW. NOD-like receptor family, pyrin domain containing 3 (NLRP3) contributes to inflammation, pyroptosis, and mucin production in human airway epithelium on rhinovirus infection. J Allergy Clin Immunol. 2019;144(3):777–787.e779. 10.1016/j.jaci.2019.05.006

Showing 50 of 51 references

Metrics
3
Citations
51
References
Details
Published
Jan 01, 2025
Vol/Issue
8
Authors
Funding
National Natural Science Foundation Award: No. 82470040
Noncommunicable Chronic Diseases-National Science and Technology Major Project Award: No. 2024ZD0529600, No. 2024ZD0529601
Major Project of Guangzhou National Laboratory Award: GZNL2024A02003
National Natural Science Foundation - Outstanding Youth Fund Award: No. 82222001
Guangzhou Science and Technology Plans Award: No. 2024A04J6495, 2024A03J1206, 2023B03J0407
Plan on Enhancing Scientific Research in Guangzhou Medical University Award: grant number not applicable
Cite This Article
Zhao-ming Chen, Jia-hui He, Rui-di Tang, et al. (2025). NLRP3 Inflammasome Activation Modulates Neutrophil Extracellular Trap Formation and Aggravates Airway Inflammation in Bronchiectasis. Research, 8. https://doi.org/10.34133/research.0958
Related

You May Also Like